Skin biopsy highlighted an infiltration of CD56+CD4+CD3+/− pathological cells with focal expression of MUM1 posing for a diagnosis of BPDCN. The gene discussed is NCAM1; the disease is CD4+/CD56+ hematodermic neoplasm.